What does the Build Back Better Act actually mean for the health care industry?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Biden’s big bet on antivirals
In a little-noticed regulatory move in September, the federal government moved to give pharmacists a much larger pandemic-response role — specifically, allowing them to prescribe and administer Covid-19 treatments.
